Property and Equipment

12 Months Ended

Dec. 31, 2024

Property, Plant and Equipment [Abstract]

Property and Equipment

Property and Equipment

Property and equipment consisted of the following:

	As of December 31,
	2024		2023
Capitalized software	$	32,171	$	32,171
Laboratory equipment	18,267		15,538
Leasehold improvements	14,655		14,614
Computer equipment	6,912		5,819
Building under finance lease	4,529		4,529
Equipment under finance leases	3,293		2,604
Furniture, fixtures and other equipment	584		550
Construction in-progress	4,960		3,106
Total property and equipment	85,371		78,931
Less: accumulated depreciation and amortization	(52,478)		(46,452)
Property and equipment, net	$	32,893	$	32,479

For the years ended December 31, 2024 and 2023, depreciation and amortization expense was $7.9 million and $19.7 million, respectively, which included software amortization expense of zero and $6.6 million for the years ended December 31, 2024 and 2023. For intangible amortization, see Note 6, “Intangible Assets”.

For the year ended December 31, 2024, the Company recorded the following:

•$0.6 million charge to accelerate the depreciation, net of trade-in credits, for certain lab equipment that was sold during the period as a trade-in associated with the purchase of new lab equipment; and

•$0.3 million charge to accelerate the depreciation for certain lab equipment that was retired during the period.

For the year ended December 31, 2023, the Company recorded the following:

•$4.0 million charge to accelerate the amortization for certain capitalized software projects associated with Legacy Sema4 that were not expected to be utilized;

•$9.9 million non-cash impairment charges (of which $5.6 million was allocated to the right-of-use asset associated with the sublease), driven by indicators of impairment related to the Icahn School of Medicine at Mount Sinai (“ISMMS“) sublease agreements during the first and third quarters of 2023; and

•$1.7 million net gain on sale of assets primarily associated with the closure of Legacy Sema4 facilities.

Depreciation and amortization expense is included within the statements of operations and comprehensive loss as follows:

	Year Ended December 31,
	2024		2023
Cost of services	$	4,047	$	4,350
Research and development	923		6,710
Selling and marketing	—		2
General and administrative	2,958		8,647
Total depreciation and amortization expense	$	7,928	$	19,709